Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations

By Uno Tsukasa   Niioka Takenori   Hayakari Makoto   Yasui-Furukori Norio   Sugawara Kazunobu   Tateishi Tomonori  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treatments

By  

Current Drug Metabolism, Vol. 13, Iss. 9, 2012-11 ,pp. : 1303-1312

Bentham Science Publishers

Access to resources Recommend Favorite

Oral contraceptives: Vertigo (first report with ethinylestradiol/drospirenone, ethinylestradiol/levonorgestrel and ethinylestradiol/gestodene): 10 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects

By Xu Hong-Rong   Chen Wei-Li   Li Xue-Ning   Chu Nan-Nan  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 8, 2010-08 ,pp. : 947-952

Informa Healthcare

Access to resources Recommend Favorite

Transcriptional Regulation of CYP2C19 and its Role in Altered Enzyme Activity

By  

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1196-1204

Bentham Science Publishers

Access to resources Recommend Favorite